New England Journal of Medicine · 2012 · 277 citations · 3 references
MedicineOrthopedic SurgeryBone MetabolismBone HealthBone Metabolism PharmacotherapyFracture ManagementFracture PreventionOsteoporosisOsteoporosis PharmacotherapyAdjuvant Bisphosphonate TherapyBisphosphonate Therapy ManagementFracturesSequential Osteoporosis TherapyTreatment With Bisphosphonates
There is controversy over the ideal duration of bisphosphonate therapy for osteoporosis, given reports of atypical subtrochanteric fractures and osteonecrosis of the jaw. But some subgroups of patients may benefit from continuing therapy beyond 3 to 5 years.
3
Effects of Continuing or Stopping Alendronate After 5 Years of Treatment
Dennis M. Black, Ann V. Schwartz, Kristine E. Ensrud et al. · JAMA · 2006 · 1.4K citations
Dennis M. Black, Ian R. Reid, Steven Boonen et al. · Journal of Bone and Mineral Research · 2011 · 695 citations · Full text